GETI-B:STO
Getinge publ AB
SEKÂ 246.40
arrow_downward
-0.32%(-0.80) 1D
Oct 2, 5:29:58 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GETI-B...
Open
SEKÂ 247.20
High
SEKÂ 248.80
Low
SEKÂ 245.90
Mkt. cap
62.62B
Avg. vol.
578.42K
Volume
275.73K
Dividend
1.93%
Quarterly dividend
SEKÂ 1.19
Ex-dividend date
Apr 22, 2026
P/E ratio
25.10
52-wk high
SEKÂ 251.40
52-wk low
SEKÂ 175.90
EPS
SEKÂ 9.82
Shares outstanding
254.15M
No. of employees
12K
Open
SEKÂ 247.20
High
SEKÂ 248.80
Low
SEKÂ 245.90
Mkt. cap
62.62B
Avg. vol.
578.42K
Volume
275.73K
Dividend
1.93%
Quarterly dividend
SEKÂ 1.19
Ex-dividend date
Apr 22, 2026
P/E ratio
25.10
52-wk high
SEKÂ 251.40
52-wk low
SEKÂ 175.90
EPS
SEKÂ 9.82
Shares outstanding
254.15M
No. of employees
12K
News stories
From web sources and news partners
BigGo Finance
·
1 hour ago
Dow extends gains, rises 250 points to 51,176 as jobs report cools rate-hike bets
Stocktwits
·
33 minutes ago
S&P 500, Nasdaq, Dow End Week Higher As Weak Jobs Report Cools Rate Hike Bets — NVDA, BA, SPCX, RIVN, APLD In Focus
U.S. Global Investors
·
2 hours ago
Gold Stumbled in September, but Gold Miners Beat Every Sector in the S&P 500
marketscreener.com
·
2 hours ago
S&P maintains Romania at 'BBB-/A-3'
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB